Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer

被引:0
|
作者
Moati, E. [1 ]
Blons, H. [2 ]
Taly, V. [3 ]
Garlan, F. [3 ]
Shu-Fang, W-R. [3 ]
Pietrasz, D. [3 ]
Didelot, A. [3 ]
Garrigou, S. [3 ]
Saint, A. [4 ]
Pernot, S. [1 ]
Taieb, J. [1 ]
Laurent-Puig, P. [3 ]
Zaanan, A. [1 ]
机构
[1] Hop Europeen Georges Pompidou, Dept Gastroenterol & Digest Oncol, Paris, France
[2] Hop European George Pompidou, Mol Oncol, Paris, France
[3] Univ Paris Diderot, Univ Paris Descartes, Sorbonne Univ, Ctr Rech Cordeliers,USPC,CNRS,INSERM, Paris, France
[4] Hop European George Pompidou, Oncol Digest, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
623P
引用
收藏
页码:236 / 236
页数:1
相关论文
共 50 条
  • [31] RAS testing in metastatic colorectal cancer: advances in Europe
    Van Krieken, J. Han J. M.
    Rouleau, Etienne
    Ligtenberg, Marjolijn J. L.
    Normanno, Nicola
    Patterson, Scott D.
    Jung, Andreas
    VIRCHOWS ARCHIV, 2016, 468 (04) : 383 - 396
  • [32] Concomitant BRAF and RAS Mutations in Metastatic Colorectal Cancer
    Srivastav, Jigisha
    Lima, Caio Rocha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S309 - S310
  • [33] RAS testing in metastatic colorectal cancer: advances in Europe
    J Han JM Van Krieken
    Etienne Rouleau
    Marjolijn J. L. Ligtenberg
    Nicola Normanno
    Scott D. Patterson
    Andreas Jung
    Virchows Archiv, 2016, 468 : 383 - 396
  • [34] RAS mutations in metastatic colorectal cancer in central Tunisia
    Melliti, R.
    Belaid, I.
    Makram, H.
    Imene, C.
    Faten, E.
    Ammar, N.
    Ben Fatma, L.
    Mokni, M.
    Slim, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S194 - S195
  • [35] CLINICAL OUTCOMES IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH BEVACIZUMAB AND K-RAS MUTATION STATUS
    Luis, I. V.
    Ribeiro, J.
    Matias, M.
    Casanova, M.
    Semedo, M.
    Pereira, S.
    Miltenberger-Miltenyi, G.
    Castro, A.
    Costa, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 218 - 218
  • [36] Evolution of RAS testing over time: factors influencing mutation rates in metastatic colorectal cancer patients
    Dufraing, Kelly
    Keppens, Cleo
    Tack, Veronique
    Siebers, Albert Gerrit
    Kafatos, George
    Dube, Sabada
    Demonty, Gaston
    Lowe, Kimberly
    Kroeze, Leonie Ilse
    Ligtenberg, Marjolijn
    Normanno, Nicola
    Tembuyser, Lien
    Sara, Vander Borght
    van Krieken, Joannes Henricus
    Dequeker, Elisabeth Marie C.
    COLORECTAL CANCER, 2020, 9 (01)
  • [37] Mutation spectra of RAS gene family in colorectal cancer
    Chang, Yu-Yao
    Lin, Pei-Ching
    Lin, Hung-Hsin
    Lin, Jen-Kou
    Chen, Wei-Shone
    Jiang, Jeng-Kai
    Yang, Shung-Haur
    Liang, Wen-Yih
    Chang, Shih-Ching
    AMERICAN JOURNAL OF SURGERY, 2016, 212 (03): : 537 - +
  • [38] Undetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer?
    Bouchahda, M.
    Karaboue, A.
    Saffroy, R.
    Hamelin, J.
    Bosselut, N.
    Lemoine, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014
    Lievre, Astrid
    Merlin, Jean-Louis
    Sabourin, Jean-Christophe
    Artru, Pascal
    Tong, Sabine
    Libert, Lucie
    Audhuy, Francois
    Gicquel, Corinne
    Moureau-Zabotto, Laurence
    Ossendza, Roch-Anicet
    Laurent-Puig, Pierre
    Ducreux, Michel
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (05) : 507 - 512
  • [40] Droplet digital PCR of circulating tumour DNA for the detection of RAS/BRAF mutation in metastatic colorectal cancer
    Van Cutsem, E.
    Lesniewski-Kmak, K.
    Saunders, M. P.
    Wasan, H.
    Argiles, G.
    Borg, C.
    Creemers, G-J. M.
    Fedyanin, M.
    Glynne-Jones, R.
    Pfeiffer, P.
    Punt, C. J. A.
    Stroyakovskiy, D.
    Ten Tije, A. J.
    van de Wouw, A.
    Cattan, V.
    Desachy, G.
    Amellal, N.
    Moiseyenko, V. M.
    ANNALS OF ONCOLOGY, 2018, 29